Results 231 to 240 of about 411,291 (407)

Percutaneous Coronary Interventions [PDF]

, 2001

openalex   +1 more source

Impact of mitral valve transcatheter edge‐to‐edge repair on haemodynamic parameters in cardiogenic shock

ESC Heart Failure, EarlyView.
Abstract Background Transcatheter edge‐to‐edge repair (TEER) has been shown to be an effective treatment option for patients experiencing cardiogenic shock (CS) with concomitant high‐grade mitral valve regurgitation. However, haemodynamic changes following M‐TEER have not been thoroughly investigated. Afterload mismatch, leading to the deterioration of
Michal Droppa, Dominik Rath, Philippa Jaeger, Ioannis Toskas, Monika Zdanyte, Andreas Goldschmied, Jürgen Schreieck, Meinrad Gawaz, Tobias Geisler   +8 more
wiley   +1 more source

Cardiac arrest and post-discharge mortality in patients with myocardial infarction: A large-scale nationwide registry analysis

Resuscitation Plus
Background: Cardiac arrest is a serious complication of acute myocardial infarction. The implementation of contemporary approaches to acute myocardial infarction management, including urgent revascularization procedures, has led to significant ...
Hirohiko Ando, Mitsuaki Sawano, Shun Kohsaka, Hideki Ishii, Atomu Tajima, Wataru Suzuki, Ayako Kunimura, Yusuke Nakano, Ken Kozuma, Tetsuya Amano   +9 more
doaj  

Comparing the Outcomes of Thrombus Aspiration Versus Standard Percutaneous Coronary Intervention in ST-Segment Elevation Myocardial Infarction Patients Undergoing Primary Percutaneous Coronary Intervention. [PDF]

Cureus
Karumuri D, Sankaran R, S S, Senguttuvan NB, Jayanthy Venkata B, Balakrishnan VK, Krishnamurthy P, Muthyala V.   +7 more
europepmc   +1 more source

Percutaneous coronary intervention: current perspective.

, 2001
Tomoaki Hinohara
openalex   +2 more sources

Pre‐admission beta‐blocker therapy and outcomes in cardiogenic shock: Insights from the Altshock‐2 Registry

ESC Heart Failure, EarlyView.
Among 668 with cardiogenic shock included in the multicentre prospective Altshock‐2 registry, 299 patients (44.8%) received pre‐admission beta‐blocker therapy. Previous beta‐blocker therapy influenced the early hemodynamic response to vasoactive drugs, but it was not associated with in‐hospital mortality.
Matteo Pagnesi, Mauro Riccardi, Alice Sacco, Giovanni Tavecchia, Giovanna Viola, Simone Frea, Martina Briani, Letizia Fausta Bertoldi, Maurizio Bertaina, Luciano Potena, Serafina Valente, Marco Marini, Gaetano Maria De Ferrari, Nicoletta D'Ettore, Astrid Cardinale, Rita Camporotondo, Matteo Rota, Guido Tavazzi, Nuccia Morici, Federico Pappalardo, Marco Metra, on behalf of the Altshock‐2 investigators   +21 more
wiley   +1 more source

Impella-Protected High-Risk Percutaneous Coronary Intervention in the Elderly: Balancing Feasibility and Necessity. [PDF]

J Am Heart Assoc
Bogerd M, Henriques JPS.
europepmc   +1 more source

A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation.

Journal of the American College of Cardiology, 2004
R. Mehran, E. Aymong, E. Nikolsky, Zoran Lasić, I. Iakovou, M. Fahy, G. Mintz, A. Lansky, J. Moses, G. Stone, M. Leon, G. Dangas   +11 more
semanticscholar   +1 more source

Current and novel biomarkers in cardiogenic shock

European Journal of Heart Failure, EarlyView.
A summary of current and novel biomarkers and their potential stages of release in cardiogenic shock. The diagram illustrates the proposed release of the biomarkers during the different stages of cardiogenic shock: progression from cardiac dysfunction/stress, through to inflammation and end‐organ dysfunction.
Victor Galusko, Florian A. Wenzl, Christophe Vandenbriele, Vasileios Panoulas, Thomas F. Lüscher, Diana A. Gorog   +5 more
wiley   +1 more source